Navigating Communication on Clinical Trials in Oncology

Navigating Communication on Clinical Trials in Oncology

Register here

Wednesday, August 20th, 2025 at 2pm ET

Clinical trials are the cornerstone of advancing cancer treatment, offering patients cutting-edge therapies while contributing to critical research. However, effective communication between patients and oncologists is essential to ensure understanding, participation, and optimal outcomes. In Cancer Nation’s 2024 State of Survivorship survey, participation in clinical trials remains consistent, with key drivers being the doctor’s recommendation (51%) and the prospect of access to new treatments (28%). Among patients who did not participate in clinical trials, 74% of patients said that they were not asked, which remains the largest barrier. Patients also cited concerns about side effects, treatment protocols, and location as secondary barriers, with these concerns being more prominent among younger patients and patients of color.

This webinar will discuss the role of communication in clinical trial participation. Attendees will gain insight into how communication can influence trial participation, improve patient understanding, and address concerns such as eligibility, side effects, and informed consent. Participants will also learn about resources related to clinical trial participation available to oncology professionals and their patients.

Featured speakers for this presentation:

• Kristi Mitchell, MPH of Health Equity Outcomes
• Don S. Dizon, MD of Tufts University
• Joseph Unger, PhD of Fred Hutch Cancer Center